No insider-trading filing for this company in the last two years.
| Filed | Acquirer | Direction | Mode | Acquired | Sold | Holding after | Promoter |
|---|---|---|---|---|---|---|---|
| 7 Apr 2021 | Ipca Laboratories Limited Reg29(2) |
Others | Preferential Allotment | — | — | 49.65% | Yes |
| 7 Apr 2021 | Ipca Laboratories Limited Reg29(2) |
Others | Preferential Allotment | — | — | 0.00% | Yes |
| 21 May 2020 | Ipca Laboratories Limited Reg29(2) |
Acquisition | Others | 1,620,000 4.98% |
— | 44.67% | Yes |
| 5 Feb 2020 | IPCA Laboratories Ltd Reg29(2) |
Acquisition | Preferential Allotment | 1,370,000 7.61% |
— | 39.69% | Yes |
| 1 Apr 2019 | Avinash Ravi along with PAC Reg29(2) |
Acquisition | Others | 863,989 5.20% |
— | 29.93% | Yes |
| 27 Mar 2019 | IPCA Laboratories Limited Reg29(2) |
Acquisition | Others | 1,675,095 10.07% |
— | 34.73% | Yes |
| 13 Jun 2016 | Hemalata Ravi Reg29(2) |
Acquisition | Others | 680,000 4.95% |
— | 16.18% | Yes |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
